Investors

CORPORATE PRESENTATION

SHARE STRUCTURE

As of April 19^th, 2024

Market Capitalization (@ $0.17)	$25,946,710
Shares Issued and Outstanding	152,627,703
Stock Options	6,847,500
Warrants*	20,741,768
Fully Diluted Shares	180,216,971
Major Shareholders	Eric Sprott: 10.5% William M. Sheriff: 9.6%

WARRANTS

10-Apr-25	1,950,000	$0.10
20-Dec-25	11,875,000	$0.06
20-Dec-25	1,225,000	$0.06
19-Apr-26	5,201,400	$0.25
19-Apr-26	490,368	$0.17

Fact Sheet

STOCK INFORMATION

Exchange: CSX	Symbol: CTOC
Last Price:	Volume:
Bid Price:	52 Week High:
Ask Price:	52 Week Low:

VIDEO

C2C Gold looks to be very active in 2023 with large land package in Newfoundland

C2C Gold Presents at OTC Virtual Investor Conference, October 2021

Newfoundland Gold Virtual Investors Day 2 - Keynote: Shawn Ryan

Newfoundland Gold Virtual Investors Day 2 - Panel: Chris Healey, Janet Sheriff & Craig Roberts

SPROTT MONEY: Gold and Silver Ready for Summer - Weekly Wrap Up 5.28.21

WEBINAR WITH JANET LEE-SHERIFF & SHAWN RYAN

Newfoundland Gold Virtual Investors Day 3 - Keynote: Richard Goldfarb

PHOTO GALLERY

MEDIA

June 7, 2021

Newfoundland’s Area Gold Play: A 21st Century Klondike Gold Rush Analog?

May 11, 2021

The Globe and Mail: Like it or not, natural resources are still the only way forward for Newfoundland

January 27, 2021

Island gold: central Newfoundland becoming hotbed for mining activity

December 6, 2020

A low-carbon future means a big demand for key minerals. Can N.L.’s mines cash in?

FINANCIALS

Annual Financial Statements 2023
Q3 Financial Statement	For the nine months ended September 30, 2023
Q3 MD & A	For the nine months ended September 30, 2023
Q2 Financial Statement	For the six months ended June 30, 2023
Q2 MD & A	For the six months ended June 30, 2023
Q1 Financial Statement	For the three months ended March 31, 2023 and 2022
Q1 MD & A	For the three months ended March 31, 2023 and 2022

Annual Financial Statement 2022	For the years ended December 31, 2022 and 2021
Q4 MD & A	For the year ended December 31, 2022
Q3 Financial Statement	For the nine months ended September 30, 2022
Q3 MD & A	For the nine months ended September 30, 2022
Q2 Financial Statement	For the six months ended June 30, 2022
Q2 MD & A	For the six months ended June 30, 2022
Q1 Financial Statement	For the three months ended March 31, 2022 and 2021
Q1 MD & A	For the three months ended March 31, 2022 and 2021

Annual Financial Statement 2021	For the years ended December 31, 2021 and 2020
Q4 MD & A	For year ended December 31, 2021
Q3 Financial Statement	For the nine months ended September 30, 2021
Q3 MD & A	For the nine months ended September 30, 2021
Q2 Financial Statement	For the six months ended June 30, 2021
Q2 MD & A	For the six months ended June 30, 2021
Q1 Financial Statement	For the three months ended March 31, 2021 and 2020
Q1 MD & A	For the three months ended March 31, 2021 and 2020

Annual Financial Statement 2020	For the years ended December 31, 2020 and 2019
MD & A	For year ended December 31, 2020
Q3 Financial Statement	For the nine months ended September 30, 2020
Q3 MD & A	For the nine months ended September 30, 2020
Q2 Financial Statement	For the six months ended June 30, 2020
Q2 MD & A	For the six months ended June 30, 2020
Q1 Financial Statement	For the three months ended March 31, 2020 and 2019
Q1 MD & A	For the three months ended March 31, 2020 and 2019

Annual Financial Statement 2019	For the years ended December 31, 2019 and 2018
MD & A	For year ended December 31, 2019
Q3 Financial Statement	For the nine months ended September 30, 2019
Q3 MD & A	For the nine months ended September 30, 2019
Q2 Financial Statement	For the six months ended June 30, 2019
Q2 MD & A	For the six months ended June 30, 2019
Q1 Financial Statement	For the three months ended March 31, 2019 and 2018
Q1 MD & A	For the three months ended March 31, 2019 and 2018

Annual Financial Statement 2018	For the years ended December 31, 2018 and 2017
MD & A	For year ended December 31, 2018
Q3 Financial Statement	For the nine months ended September 30, 2018 and 2017
Q3 MD & A	For the nine months ended September 30, 2018
Q2 Financial Statement	For the six months ended June 30, 2018
Q2 MD & A	For the six months ended June 30, 2018
Q1 Financial Statement	For the three months ended March 31, 2018 and 2017
Q1 MD & A	For the three months ended March 31, 2018 and 2017

Annual Financial Statement 2017	For the years ended December 31, 2017 and 2016
MD & A	For year ended December 31, 2017
Q3 Financial Statement	For the nine months ended September 30, 2017
Q3 MD & A	For the nine months ended September 30, 2017
Q2 Financial Statement	For the six months ended June 30, 2017
Q2 MD & A	For the six months ended June 30, 2017
Q1 Financial Statement	For the three months ended March 31, 2017 and 2016
Q1 MD & A	For the three months ended March 31, 2017

Annual Financial Statement 2016	For the years ended December 31, 2016 and 2015
MD & A	For year ended December 31, 2016
Q3 Financial Statement	For the nine months ended September 30, 2016
Q3 MD & A	For the nine months ended September 30, 2016
Q2 Financial Statement	For the six months ended June 30, 2016
Q2 MD & A	For the six months ended June 30, 2016
Q1 Financial Statement	For the three months ended March 31, 2016 and 2015
Q1 MD & A	For the three months ended March 31, 2016 and 2015